Literature DB >> 23467232

Resistance revealed in acute lymphoblastic leukemia.

Jon C Aster, Daniel J DeAngelo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23467232     DOI： 10.1038/nm.3119

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  14 in total

1.  A somatic EZH2 mutation in childhood acute myeloid leukemia.

Authors:  T Ernst; A Pflug; J Rinke; J Ernst; U Bierbach; J F Beck; A Hochhaus; B Gruhn
Journal:  Leukemia       Date:  2012-01-23       Impact factor: 11.528

Review 2.  Childhood acute lymphoblastic leukemia: update on prognostic factors.

Authors:  Lynda M Vrooman; Lewis B Silverman
Journal:  Curr Opin Pediatr       Date:  2009-02       Impact factor: 2.856

Review 3.  Mutant BRAF melanomas--dependence and resistance.

Authors:  Poulikos I Poulikakos; Neal Rosen
Journal:  Cancer Cell       Date:  2011-01-18       Impact factor: 31.743

4.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.

Authors:  Jinghui Zhang; Li Ding; Linda Holmfeldt; Gang Wu; Sue L Heatley; Debbie Payne-Turner; John Easton; Xiang Chen; Jianmin Wang; Michael Rusch; Charles Lu; Shann-Ching Chen; Lei Wei; J Racquel Collins-Underwood; Jing Ma; Kathryn G Roberts; Stanley B Pounds; Anatoly Ulyanov; Jared Becksfort; Pankaj Gupta; Robert Huether; Richard W Kriwacki; Matthew Parker; Daniel J McGoldrick; David Zhao; Daniel Alford; Stephen Espy; Kiran Chand Bobba; Guangchun Song; Deqing Pei; Cheng Cheng; Stefan Roberts; Michael I Barbato; Dario Campana; Elaine Coustan-Smith; Sheila A Shurtleff; Susana C Raimondi; Maria Kleppe; Jan Cools; Kristin A Shimano; Michelle L Hermiston; Sergei Doulatov; Kolja Eppert; Elisa Laurenti; Faiyaz Notta; John E Dick; Giuseppe Basso; Stephen P Hunger; Mignon L Loh; Meenakshi Devidas; Brent Wood; Stuart Winter; Kimberley P Dunsmore; Robert S Fulton; Lucinda L Fulton; Xin Hong; Christopher C Harris; David J Dooling; Kerri Ochoa; Kimberly J Johnson; John C Obenauer; William E Evans; Ching-Hon Pui; Clayton W Naeve; Timothy J Ley; Elaine R Mardis; Richard K Wilson; James R Downing; Charles G Mullighan
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

Review 5.  Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.

Authors:  Carlos M Galmarini; Lars Jordheim; Charles Dumontet
Journal:  Leuk Lymphoma       Date:  2003-07

6.  Relation of 5'-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia.

Authors:  R Pieters; D R Huismans; A H Loonen; G J Peters; K Hählen; A van der Does-van den Berg; E R van Wering; A J Veerman
Journal:  Leuk Res       Date:  1992-09       Impact factor: 3.156

7.  Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

Authors:  Françoise Huguet; Thibaut Leguay; Emmanuel Raffoux; Xavier Thomas; Kheira Beldjord; Eric Delabesse; Patrice Chevallier; Agnes Buzyn; André Delannoy; Yves Chalandon; Jean-Paul Vernant; Marina Lafage-Pochitaloff; Agnès Chassevent; Véronique Lhéritier; Elizabeth Macintyre; Marie-Christine Béné; Norbert Ifrah; Hervé Dombret
Journal:  J Clin Oncol       Date:  2009-01-05       Impact factor: 44.544

8.  Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.

Authors:  Adele K Fielding; Susan M Richards; Rajesh Chopra; Hillard M Lazarus; Mark R Litzow; Georgina Buck; I Jill Durrant; Selina M Luger; David I Marks; Ian M Franklin; Andrew K McMillan; Martin S Tallman; Jacob M Rowe; Anthony H Goldstone
Journal:  Blood       Date:  2006-10-10       Impact factor: 22.113

9.  Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL.

Authors:  Gannie Tzoneva; Arianne Perez-Garcia; Zachary Carpenter; Hossein Khiabanian; Valeria Tosello; Maddalena Allegretta; Elisabeth Paietta; Janis Racevskis; Jacob M Rowe; Martin S Tallman; Maddalena Paganin; Giuseppe Basso; Jana Hof; Renate Kirschner-Schwabe; Teresa Palomero; Raul Rabadan; Adolfo Ferrando
Journal:  Nat Med       Date:  2013-02-03       Impact factor: 53.440

10.  Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia.

Authors:  Julia A Meyer; Jinhua Wang; Laura E Hogan; Jun J Yang; Smita Dandekar; Jay P Patel; Zuojian Tang; Paul Zumbo; Sheng Li; Jiri Zavadil; Ross L Levine; Timothy Cardozo; Stephen P Hunger; Elizabeth A Raetz; William E Evans; Debra J Morrison; Christopher E Mason; William L Carroll
Journal:  Nat Genet       Date:  2013-02-03       Impact factor: 38.330
View more
  1 in total

1.  Oligomeric interface modulation causes misregulation of purine 5´-nucleotidase in relapsed leukemia.

Authors:  Aleš Hnízda; Jana Škerlová; Milan Fábry; Petr Pachl; Martina Šinalová; Lukáš Vrzal; Petr Man; Petr Novák; Pavlína Řezáčová; Václav Veverka
Journal:  BMC Biol       Date:  2016-10-19       Impact factor: 7.431
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.